Becker's Healthcare August 16, 2024
Paige Twenter

Some patients are dose splitting their GLP-1 injection pens as they struggle to pay thousands of dollars for the diabetes and weight loss medications, The Atlantic reported Aug. 15.

Type 2 diabetes drugs like Ozempic and Mounjaro, as well as weight loss medications such as Zepbound and Wegovy, can cost between $940 and $1,300 per month without insurance. Some insurers, including Medicare, don’t cover weight loss drugs. For those who cannot afford the blockbuster medicines or want to mitigate side effects, they’re dividing doses.

Drugmakers and physicians warn against this practice,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Patient / Consumer, Pharma / Biotech
Shifting Our Healthcare Delivery Model from Reactive to Proactive
Medtronic, Tempus testing AI to find potential TAVR patients
Why Tufts Medicine ended its hospital-at-home program
How the Triadic Model of Interpreter, Patient and Provider has Elevated Healthcare Communications
Is a lack of understanding driving alcohol-related deaths in the U.S.?

Share This Article